Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Page 1
Management of Acute and Recurrent Pericarditis: JACC State-of-the-Art Review.
J Am Coll Cardiol. 2020 Jan 7;75(1):76-92. doi: 10.1016/j.jacc.2019.11.021.
J Am Coll Cardiol. 2020.
PMID: 31918837
Free article.
Review.
Acute pericarditis is generally self-limited and not life-threatening; yet, it may cause significant short-term disability, be complicated by either a large pericardial effusion or tamponade, and carry a significant risk of recurrence. ...
Acute pericarditis is generally self-limited and not life-threatening; yet, it may cause significant short-term disability, be compli …
Low Density Lipoprotein Receptor-Related Protein-1 in Cardiac Inflammation and Infarct Healing.
Potere N, Del Buono MG, Mauro AG, Abbate A, Toldo S.
Potere N, et al. Among authors: mauro ag.
Front Cardiovasc Med. 2019 Apr 26;6:51. doi: 10.3389/fcvm.2019.00051. eCollection 2019.
Front Cardiovasc Med. 2019.
PMID: 31080804
Free PMC article.
Review.
Additional therapies are therefore warranted to blunt the inflammatory response associated with ischemia and reperfusion and prevent long-term adverse events. Low-density lipoprotein receptor-related protein 1 (LRP1) is a ubiquitous endocytic cell surface receptor with the …
Additional therapies are therefore warranted to blunt the inflammatory response associated with ischemia and reperfusion and prevent long- …
Item in Clipboard
Sacubitril/Valsartan Averts Adverse Post-Infarction Ventricular Remodeling and Preserves Systolic Function in Rabbits.
Torrado J, Cain C, Mauro AG, Romeo F, Ockaili R, Chau VQ, Nestler JA, Devarakonda T, Ghosh S, Das A, Salloum FN.
Torrado J, et al. Among authors: mauro ag.
J Am Coll Cardiol. 2018 Nov 6;72(19):2342-2356. doi: 10.1016/j.jacc.2018.07.102.
J Am Coll Cardiol. 2018.
PMID: 30384891
Free article.
CONCLUSIONS: Reperfusion therapy with SAC/VAL or VAL offers robust acute infarct-sparing benefits; however, SAC/VAL treatment offered superior short-term and long-term benefits in preventing MI-induced LV dysfunction compared with VAL. ...
CONCLUSIONS: Reperfusion therapy with SAC/VAL or VAL offers robust acute infarct-sparing benefits; however, SAC/VAL treatment offered superi …
Item in Clipboard
A Preclinical Translational Study of the Cardioprotective Effects of Plasma-Derived Alpha-1 Anti-trypsin in Acute Myocardial Infarction.
Mauro AG, Mezzaroma E, Marchetti C, Narayan P, Del Buono MG, Capuano M, Prestamburgo A, Catapano S, Salloum FN, Abbate A, Toldo S.
Mauro AG, et al.
J Cardiovasc Pharmacol. 2017 May;69(5):273-278. doi: 10.1097/FJC.0000000000000474.
J Cardiovasc Pharmacol. 2017.
PMID: 28195949
Finally, we tested whether a single dose at reperfusion was sufficient to maintain a benefit in the longer term (7 days). Infarct size was measured by 3 different and independent methodologies: pathology, plasma levels of troponin I, and wall motion abnormalities at echoca …
Finally, we tested whether a single dose at reperfusion was sufficient to maintain a benefit in the longer term (7 days). Infarct siz …
Item in Clipboard
Cite
Cite